Anti-dsDNA: choice of assay in relation to clinical value
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Antibodies to DNA are quite specific for systemic lupus erythematosus (SLE) and occur in the majority of SLE patients. Therefore, their detection is an important diagnostic aid to the clinician. Detection of anti-dsDNA may precede the diagnosis of SLE by more than a year. Fluctuations in the level of anti-dsDNA in an individual patient may give important information on the clinical status of the patient. Four of the most important methods developed for the measurement of anti-dsDNA antibodies will be discussed in this paper: the Farr assay, the PEG assay, the indirect immunofluorescence test on Crithidia luciliae and the ELISA. They will also be compared with one commercially available (Farr) assay, the Amersham anti-dsDNA kit. Each method, detects a part of the spectrum of anti-dsDNA antibodies produced by a patient. The Farr assay is the most specific for SLE; however, milder forms of the disease in which patients have only low avidity anti-dsDNA may easily be missed by this technique. Clinically, high avidity anti-dsDNA is related more frequently to the occurrence of nephritis, whereas low avidity anti-dsDNA antibodies are found more often in patients with central nervous system involvement. Traditionally, SLE is considered an immune-complex disease, in which inflammatory processes are initiated by local deposition of DNA/anti-dsDNA complexes. More recently, a major role was thought to be played by crossreactions of anti-dsDNA with tissue constituents. Our current view, ho…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, not all assays will generate similar values, even after standardization [80].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [80]
In the citing paper
“As the Farr assay includes ammonium sulphate precipitation at high salt concentrations, a condition that dissociates dsDNA-anti-dsDNA complexes of low avidity, 4 this assay detects only antibodies with high avidity. 5”
In the citing paper
“High avidity anti-dsDNA antibodies are more specific for SLE than those with low avidity 5”
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 1×
“General comparison of the five anti-dsDNA assays using sera of patients with SLE defned according to the revised criteria of the American Rheumatism Association [ 33 ], leads to high levels of correlations between the various assays.”
MethodAntinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514 · cited 1×
“SLE has been termed an autoimmune disease because many antibodies detected in the circulation of such patients are directed to autoantigens, in particular nucleic acids and proteins associated with nucleic acids [2, 3].”
BackgroundTer Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572 · cited 1×
“An illustration of such a pattern is given in Fig. 3. These observations have been confirmed recently by Ter Borg et al. [ 46 ].”
BackgroundAarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Furie, B., Schwartz, R. S., & Stollar, B. D. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.4.897 · Cited by 536
ANTIBODIES TO POLYNUCLEOTIDES IN HUMAN SERA: ANTIGENIC SPECIFICITY AND RELATION TO DISEASE
Koffler, D., Carr, R., Agnello, V., Thoburn, R., & Kunkel, H. G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.1.294 · Cited by 510
Polyspecificity of Monoclonal Lupus Autoantibodies Produced by Human-Human Hybridomas
Shoenfeld, Y., Rauch, J., Massicotte, H., Datta, S. K., André-Schwartz, J., Stollar, B. D., & Schwartz, R. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302243080802 · Cited by 450 · cited 1×
“Monoclonal antibodies to DNA were often found to crossreact with structures such as phospholipids, proteoglycans or other polynegative molecules [5, 6, 8, 51, 52].”
BackgroundRivera, J. A. (1971) · Military Medicine · doi:10.1093/milmed/136.1.96a · Cited by 446
Winfield, J. B., Faiferman, I., & Koffler, D. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108626 · Cited by 405
Wold, R. T., Young, F. E., Tan, E. M., & Farr, R. S. (1968) · Science · doi:10.1126/science.161.3843.806 · Cited by 378 · cited 1×
“Farr assay. The Farr assay employs ammonium sulphate precipitation to separate DNA/anti-dsDNA complexes from free (radiolabeled) DNA [ 21 ].”
MethodSYSTEMIC LUPUS ERYTHEMATOSUS: PROTOTYPE OF IMMUNE COMPLEX NEPHRITIS IN MAN
Koffler, D., Agnello, V., Thoburn, R., & Kunkel, H. G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.169 · Cited by 317 · cited 2×
“Autoantibodies, chronically produced by the patient, combine with their respective autoantigens to form immune complexes in the circulation and mediate tissue damage [4].”
BackgroundAnti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosus
Swaak, A. J. G., Aarden, L. A., Statius Eps, L. W. V., & Feltkamp, T. E. W. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220304 · Cited by 284 · cited 1×
“With respect to the Farr assay, Swaak et al. have found that major disease symptoms in SLE patients only occurred during a rapid decrease of the anti-dsDNA level [ 44 ].”
ResultSelf-citationRestricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus
Ebling, F., & Hahn, B. H. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230402 · Cited by 265 · cited 1×
“This model of SLE has been challenged in recent years [49], based on observed crossreactions of anti-dsDNA [8, 50 , 51].”
BackgroundPredictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
Swaak, A. J., Groenwold, J., & Bronsveld, W. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.5.359 · Cited by 224 · cited 1×
“Longitudinal studies have been performed only with the Farr assay [40, 41 ] and the PEG assay [42, 43].”
MethodSelf-citationFaaber, P., Rijke, T. P., van de Putte, L. B., Capel, P. J., & Berden, J. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112508 · Cited by 224
Self-citationSchmiedeke, T., Stöckl, F., Weber, R. W., Sugisaki, Y., Batsford, S., & Vogt, A. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.6.1879 · Cited by 150 · cited 1×
“Schmiedeke et al. [ 55 ] have shown that histones have a high intrinsic affinity for the GBM.”
BackgroundThe Specificity and Applications of Antibodies to Helical Nucleic Acid
David Stollar, B., & Erlanger, B. F. (1975) · CRC Critical Reviews in Biochemistry · doi:10.3109/10409237509102552 · Cited by 142
Cross-reactivity of anti-DNA antibodies with proteoglycans.
Faaber, P., Capel, P. J., Rijke-Schilder, G. P. M., Vierwinden, G., van de Putte, L. B. A., & Koene, R. A. P. (1984) · PubMed Central · Cited by 139
Izui, S., Lambert, P. H., & Miescher, P. A. (1977) · PubMed Central · Cited by 139
Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin.
Cairns, E., Block, J., & Bell, D. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111505 · Cited by 135 · cited 1×
“Careful studies have taught us that autoantibodies (including anti-dsDNA) can also be found in patients with autoimmune diseases other than SLE, or even in normal individuals [56, 57 ].”
BackgroundPrognostic value of anti-dsDNA in SLE.
Swaak, A. J. G., Groenwold, J., Aarden, L. A., van Eps, L. W. S., & Feltkamp, E. W. (1982) · Annals of the Rheumatic Diseases · doi:10.1136/ard.41.4.388 · Cited by 120 · cited 1×
“All exacerbations were preceded by a continuous increase in anti-dsDNA levels and were followed by a sharp drop in these levels [ 45 ].”
BackgroundSelf-citationRingold, S. (2005) · JAMA · doi:10.1001/jama.293.24.3130 · Cited by 117
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
Isenberg, D. A., Dudeney, C., Williams, W., Addison, I. E., Charles, S., Clarke, J., & Todd-Pokropek, A. E. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.6.448 · Cited by 110 · cited 2×
“Recently, comparisons between various anti-DNA assays have also been published by others [ 58-60 ].”
MethodResultJacob, L., Lety, M. A., Louvard, D., & Bach, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111692 · Cited by 109
Natural Autoantibodies Constitute a Substantial Part of Normal Circulating Immunoglobulins
Dighiero, G., Lymberi, P., Guilbert, B., Ternynck, T., & Avraméas, S. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb20863.x · Cited by 105 · cited 1×
“Careful studies have taught us that autoantibodies (including anti-dsDNA) can also be found in patients with autoimmune diseases other than SLE, or even in normal individuals [ 56 , 57].”
BackgroundCross-reactions of anti-DNA antibodies and the central dogma of lupus nephritis
Eilat, D. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90077-5 · Cited by 99 · cited 1×
“This model of SLE has been challenged in recent years [ 49 ], based on observed crossreactions of anti-dsDNA [8, 50, 51].”
BackgroundAnti-DNA antibodies and lupus nephritis: the complexity of crossreactivity
Brinkman, K., Termaat, R.-M., Berden, J. H. M., & Smeenk, R. J. T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90095-q · Cited by 98 · cited 2×
“These findings again suggest an immune complex mediated pathway leading to the induction of disease features; only now the binding to the GBM is mediated via histones [ 11 ].”
BackgroundMethodSelf-citationThe first international standard for antibodies to double stranded DNA
Feltkamp, T. E., Kirkwood, T. B., Maini, R. N., & Aarden, L. A. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.9.740 · Cited by 97
Termaat, R.-M., Brinkman, K., van Gompel, F., van den Heuvel, L. P. W. J., Veerkamp, J. H., Smeenk, R. J. T., & Berden, J. H. M. (1990) · Journal of Autoimmunity · doi:10.1016/s0896-8411(05)80019-8 · Cited by 92 · cited 2×
“Furthermore, we have found that crossreactivity with heparan sulphate, the major glycosaminoglycan of the glomerular basement membrane (GBM) was mediated by histone/DNA complexes [ 10 ].”
BackgroundSelf-citationAvidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
Smeenk, R., van der Lelij, G., & Aarden, L. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.1.73 · Cited by 90
Self-citationSwaak, T., & Smeenk, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.4.245 · Cited by 89 · cited 1×
“The diagnostic value of anti-dsDNA measured with the Farr assay was evaluated in a prospective study which took place between 1974 and 1982 [ 47 ].”
MethodSelf-citationIs anticardiolipin activity a cross‐reaction of anti‐DNA or a separate entity?
Smeenk, R. J. T., Lucassen, W. A. M., & Swaak, T. J. G. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300602 · Cited by 83 · cited 1×
“In our experience, crossreactivity of anti-dsDNA (monoclonal as well as polyclonal) seems to be inversely related to anti-dsDNA avidity [34, 53 ].”
BackgroundSelf-citationImmunology of DNA. II. The effect of size and structure of the antigen on the farr assay
Aarden, L. A., Lakmaker, F., & Feltkamp, T. E. W. (1976) · Journal of Immunological Methods · doi:10.1016/0022-1759(76)90005-3 · Cited by 78 · cited 2×
“Furthermore, the choice of assay conditions employed will influence the assay [ 22 , 24].”
MethodDouble-stranded DNA-binding capacity of serum in acute and chronic liver disease.
Jain, S., Markham, R., Thomas, H. C., & Sherlock, S. (1976) · PubMed Central · Cited by 68
Brinkman, K., Termaat, R.-M., de Jong, J., van den Brink, H. G., Berden, J. H. M., & Smeenk, R. J. T. (1989) · Research in Immunology · doi:10.1016/0923-2494(89)90122-3 · Cited by 68 · cited 3×
“Recently, we have found that certain crossreactivities of anti-dsDNA can be caused by DNA/anti-dsDNA complexes present in assayed monoclonal antibody preparations [9].”
BackgroundSelf-citationSerum DNA binding activity in healthy subjects and in rheumatic disease
Hasselbacher, P., & LeRoy, E. C. (1974) · Arthritis & Rheumatism · doi:10.1002/art.1780170110 · Cited by 66 · cited 1×
“Later, more sensitive methods were developed, and anti-DNA has also been found to occur in other clinical syndromes [ 15-18 ].”
MethodReaction patterns of monoclonal antibodies to DNA.
Smeenk, R. J. T., Brinkman, K., van den Brink, H. G., & Westgeest, A. A. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3786 · Cited by 65
Self-citationSmeenk, R. J. T., & Aarden, L. A. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90305-1 · Cited by 57 · cited 3×
“Details of this assay can be found elsewhere [ 27-30 ].”
BackgroundMethodResultSelf-citationDetection of low avidity anti‐dna antibodies in systemic lupus erythematosus
Riley, R. L., Mcgrath, H., & Taylor, R. P. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220303 · Cited by 51 · cited 1×
“Details of this assay can be found elsewhere [ 27-30 ].”
MethodDetection of anti-dsDNA as diagnostic tool.
Swaak, A. J. G., Groenwold, J., Aarden, L. A., & Feltkamp, T. E. W. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.1.45 · Cited by 44
Self-citationSmeenk, R. J. T., Brinkman, K., van den Brink, H. G., Termaat, R.-M., Berden, J. H. M., Nossent, J. C., & Swaak, T. J. G. (1990) · Clinical Rheumatology · doi:10.1007/bf02205557 · Cited by 43 · cited 1×
“However, a positive assay result then does not always indicate that the patient has SLE: anti-dsDNA of lower avidity seems to occur in diseases other than SLE [ 36 ].”
BackgroundSelf-citationMeasurements of Antibodies Specific for DNA
Aarden, L. A., & Smeenk, R. J. T. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-442702-0.50010-8 · Cited by 42
Self-citationDissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity
Smeenk, R. J. T., Van Rooijen, A., & Swaak, T. J. G. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90438-3 · Cited by 40
Self-citationThe specificity of the anti-dsDNA ELISA
Brinkman, K., Termaat, R.-M., Brink, H. V. D., Berden, J. H. M., & Smeenk, R. J. T. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90355-j · Cited by 38
Self-citationTermaat, R.-M., Brinkman, K., Nossent, J. C., Swaak, A. J. G., Smeenk, R. J. T., & Berden, J. H. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05438.x · Cited by 38
Self-citationNossent, J. C., Huysen, V., Smeenk, R. J. T., & Swaak, A. J. G. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.8.677 · Cited by 34
Self-citationA comparison of assays used for the detection of antibodies to DNA
Smeenk, R. J. T., Brinkman, K., van den Brink, H. G., & Swaak, T. J. G. (1990) · Clinical Rheumatology · doi:10.1007/bf02205553 · Cited by 33
Self-citationMeasurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
Smeenk, R. J. T., van der Lelij, G., & Aarden, L. A. (1982) · PubMed · Cited by 31
Self-citationLow avidity antibodies to dsDNA as a diagnostic tool.
Nossent, J. C., Huysen, V., Smeenk, R. J. T., & Swaak, A. J. G. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.9.748 · Cited by 27 · cited 1×
“An evaluation of the diagnostic value of low avidity anti-dsDNA has shown that of patients in whom antidsDNA was PEG-positive but Farr-negative 52% were found to have SLE [ 37 ].”
BackgroundSelf-citationAntinuclear Antibody Determination: The Present State of Diagnostic and Clinical Relevance
Smeenk, R. J. T., Westgeest, T., & Swaak, T. J. G. (1985) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748509102067 · Cited by 25
Self-citationMcGrath, H., & Biundo, J. J. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280411 · Cited by 24 · cited 1×
“Longitudinal studies have been performed only with the Farr assay [40, 41] and the PEG assay [ 42 , 43].”
MethodTzioufas, A. G., Terzoglou, C., Stavropoulos, E., Athanasiadou, S., & Moutsopoulos, H. Μ. (1990) · Clinical Rheumatology · doi:10.1007/bf02031967 · Cited by 23 · cited 2×
“In a recently published study by Tzioufas et al. [ 60 ], ELISA, Crithidia test (slides from Kallestad) and Farr assay (Amersham Kit) were compared.”
MethodResultGrennan, D. M., Sloane, D. J. P., Behan, A. A., & Dick, W. C. (1977) · Annals of the Rheumatic Diseases · doi:10.1136/ard.36.1.30 · Cited by 19
Influence of pH on the detection of low- and high-avidity anti-dsDNA
Smeenk, R. J. T., Duin, T., & Aarden, L. A. (1982) · Journal of Immunological Methods · doi:10.1016/0022-1759(82)90096-5 · Cited by 18 · cited 1×
“Furthermore, the choice of assay conditions employed will influence the assay [22, 24 ].”
MethodSelf-citationCosh, J., & Lever, J. V. (1988) · Springer eBooks · doi:10.1007/978-1-4471-1643-1_7 · Cited by 18
Antibodies against Double‐Stranded DNA in Patients with Connective Tissue Diseases
Permin, H., HALBERG, P., & Christiansen, E. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb14832.x · Cited by 15
A COMPARISON OF FOUR DIFFERENT ANTI-DNA ASSAYS
Smeenk, R. J. T. (1986) · De Gruyter eBooks · doi:10.1515/9783110884692-008 · Cited by 14
Self-citationDETECTION OF ANTIBODIES TO DNA BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
Smeenk, R. J. T. (1986) · De Gruyter eBooks · doi:10.1515/9783110884692-007 · Cited by 11
Self-citationTipping, P. G., Buchanan, R. R. C., RIGLAR, A. G., Dimech, W. J., Littlejohn, G., & Holdsworth, S. R. (1988) · Rheumatology · doi:10.1093/rheumatology/27.3.206 · Cited by 4 · cited 2×
“Recently, comparisons between various anti-DNA assays have also been published by others [ 58-60 ].”
MethodResultFeltkamp, T. E. W. (1975) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747509095622 · Cited by 2
Research works printed but not linked: 4
- Aarden LA, Smeenk R (1982) Immunochemical properties of antibodies to DNA and their influence on detection methods. In: Kalden JR, Feltkamp TEW (eds) Antibodies to nuclear antigens. Excerpta Medica, Amsterdam, pp 23?28
- Izui S, Lambert PH, Miescher PA (1977) Failure to detect circulating DNA/anti-DNA complexes by four radioimmunochemical methods in patients with SLE. Clin Exp Immunol 30:384?392
- Faaber P, Capel PJA, Rijke GPM, Vierwinden G, Putte LBA van de, Koene RAP (1984) Crossreactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 55:502?510
- Faaber P, Rijke GPM, Smeenk RJT, Capel PJA, Putte LBA van de, Berden JHM (1985) Crossreactivity of anti-DNA antibodies: a new clue for the pathogenesis of SLE? In: Peeters H (ed) Protides of the biological fluids, 33rd edn. Pergamon, London, pp 405?408
Cited by
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Linnik, M. D., Hu, J. Z., Heilbrunn, K. R., Strand, V., Hurley, F. L., Joh, T., & LJP 394 Investigator Consortium (2005) · Arthritis & Rheumatism · doi:10.1002/art.20980 · Cited by 209
Cardiel, M. H., Tumlin, J. A., Furie, R. A., Wallace, D. J., Joh, T., & Linnik, M. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23673 · Cited by 147
Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus
Arbuckle, M. R., James, J. A., Kohlhase, K. F., Rubertone, M. V., Dennis, G. J., & Harley, J. B. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00959.x · Cited by 130
Haugbro, K., Nossent, J. C., Winkler, T., Figenschau, Y., & Rekvig, O. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016303 · Cited by 113
Metadata
- Authors
- Smeenk, R. J. T., van den Brink, H. G., Brinkman, K., Termaat, R. M., Berden, J. H. M., & Swaak, A. J. G.
- Affiliations
- Radboud University Nijmegen (NL)
- ORCID
- Brinkman, K.
- Venue
- Rheumatology International
- Published
- 1991-09
- Volume
- 11
- Issue
- 3
- Pages
- 101-107
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2058665079
- Cited by
- 75
- References
- 60
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, Farr assay, indirect immunofluorescence, Crithidia luciliae, ELISA, lupus nephritis, central nervous system involvement, immune complexes, lupus diagnosis
- MeSH terms
- Antibodies, Antinuclear, DNA, Humans, Lupus Erythematosus, Systemic, Prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.